Published Jun 6, 2022

Letter from the CEO: Dr. B in 2022

Cyrus Massoumi
Written by
Cyrus Massoumi
Image of Dr. B CEO, Cyrus Massoumi, smiling in a blue shirt
Published Jun 6, 2022

We’ve come a long way since Dr. B first launched at the height of the Covid-19 crisis last year. When vaccines were first released, we saw so many desperately-needed shots go to waste due to last-minute appointment cancellations and fluctuating supply. Our team set out to build a solution and ultimately offered vaccines to over one million people across 37 states in partnership with 700+ healthcare providers.

Now that vaccines are broadly available, we’re focusing on a new challenge: reducing health inequity by making sure everyone can access the prescriptions they need. This starts with at-home Covid-19 treatments.

In keeping with our original mission, I’m proud to announce that Dr. B is now a convenient way to get prescriptions for oral Covid-19 antivirals.

We're starting with Paxlovid, one of the treatments that has received FDA emergency use authorization. We've also added Molnupiravir (Lagevrio), another at-home antiviral that has been approved for emergency use by the FDA.

In addition to Covid-19 treatments, I’m also excited to announce that our new online service will focus on expanding access to a wide range of everyday prescriptions. To get an online prescription, you'll complete an online health assessment which is reviewed by a board certified doctor. If a prescription is appropriate, it will be sent to the pharmacy of your choice.

Stay tuned for more updates as we move work to make healthcare better and more equitable for everyone. Be well.

Cyrus Massoumi, CEO & Founder of Dr. B

Back to all articles

Sign up for the free Dr. B newsletter for a weekly report on the latest in healthcare + research-based advice for staying healthy and mentally well.